James W. Wishart

Board of Directors

James W. Wishart was previously the President, CEO and a Director of Capital Genomix, Inc. from 2002 to 2007.  Prior to 2002, Mr. Wishart was the founder of Odyssey Diagnostics Inc., and has served as the CEO of Odyssey Diagnostics Inc. since its inception in 2001. During 2002, he facilitated the merger of Odyssey Diagnostics, Inc. and Capital Genomix, Inc.

From 1997 to 2001, he served as the President and CEO of DYNEX Technologies, Inc., which was a wholly owned subsidiary of Thermo Electron Corp., a $5.4 billion public Company (TMO). From 1993 to 1997, Mr. Wishart served as the President and CEO of Spectra-Tech, Inc., a subsidiary of Thermo Optek Corp., a $250 million public Company (TOC), and a worldwide leader in the development, manufacturing and marketing of FTIR microscopes, accessories and software for the analytical instrumentation market.

Mr. Wishart received his B.S. degree from Geneva College and has served on several Boards of Directors, including those of Thermo BioAnalysis, Ltd., DYNEX Technologies, Inc., Spectra-Tech, Inc., Capital Genomix, Inc., GateKeeper USA, Inc. and the S.P. Japan, Inc. Board of Directors.